| Member | Definition | Role |
|---|
| (2R,3R,4S)-4-(1-benzothiophen-3-yl)-2-ethoxy-3-(3-hydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid prop-2-enyl ester | | (2R,3R,4S)-4-(1-benzothiophen-3-yl)-2-ethoxy-3-(3-hydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid prop-2-enyl ester |
| (2S,4S)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-N-(phenylmethyl)-3,4-dihydro-2H-pyran-6-carboxamide | | (2S,4S)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-N-(phenylmethyl)-3,4-dihydro-2H-pyran-6-carboxamide |
| (4-methyl-1-piperazinyl)-(2-thieno[3,2-b][1]benzothiolyl)methanone | | (4-methyl-1-piperazinyl)-(2-thieno[3,2-b][1]benzothiolyl)methanone |
| [(2R,3R,4S)-4-(1-benzothiophen-3-yl)-2-ethoxy-3-(3-hydroxypropyl)-3,4-dihydro-2H-pyran-6-yl]-[4-(phenylmethyl)-1-piperazinyl]methanone | | [(2R,3R,4S)-4-(1-benzothiophen-3-yl)-2-ethoxy-3-(3-hydroxypropyl)-3,4-dihydro-2H-pyran-6-yl]-[4-(phenylmethyl)-1-piperazinyl]methanone |
| [(2S,4S)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-yl]-[4-(phenylmethyl)-1-piperazinyl]methanone | | [(2S,4S)-4-(1-benzothiophen-3-yl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-yl]-[4-(phenylmethyl)-1-piperazinyl]methanone |
| 1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine | A tertiary amino compound that consists of cyclohexane having piperidin-1-yl and benzothiophen-2-yl groups attached at position 1. A potent dopamine re-uptake inhibitor with a behavioral profile different from that of phencyclidine (PCP) and similar to that of cocaine. | 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine |
| 2-(5-Chlorobenzo[b]thiophen-3-yl)acetic acid | | 2-(5-Chlorobenzo[b]thiophen-3-yl)acetic acid |
| 2-[(3-chloro-1-benzothiophen-2-yl)methylideneamino]phenol | | 2-[(3-chloro-1-benzothiophen-2-yl)methylideneamino]phenol |
| 2-{1-[2-(1-benzothiophen-5-ylamino)-2-oxoethyl]cyclohexyl}acetic acid | | 2-{1-[2-(1-benzothiophen-5-ylamino)-2-oxoethyl]cyclohexyl}acetic acid |
| 2-Benzo[b]thiophen-3-ylacetic acid | | 2-Benzo[b]thiophen-3-ylacetic acid |
| 3-chloro-4-fluoro-N-(3-pyridinyl)-1-benzothiophene-2-carboxamide | | 3-chloro-4-fluoro-N-(3-pyridinyl)-1-benzothiophene-2-carboxamide |
| 3-chloro-6-methyl-N-(3-pyridinyl)-1-benzothiophene-2-carboxamide | | 3-chloro-6-methyl-N-(3-pyridinyl)-1-benzothiophene-2-carboxamide |
| 3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | | 3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide |
| 3-chloro-N-[3-(4-morpholinyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | | 3-chloro-N-[3-(4-morpholinyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide |
| 3-methyl-1-benzothiophene-2-carbaldehyde oxime | | 3-methyl-1-benzothiophene-2-carbaldehyde oxime |
| 3,4-dichloro-N-[(1-methyl-4-pyrazolyl)methyl]-1-benzothiophene-2-carboxamide | | 3,4-dichloro-N-[(1-methyl-4-pyrazolyl)methyl]-1-benzothiophene-2-carboxamide |
| 3,6-dichloro-N-(3-pyridinylmethyl)-1-benzothiophene-2-carboxamide | | 3,6-dichloro-N-(3-pyridinylmethyl)-1-benzothiophene-2-carboxamide |
| 3,6-dichloro-N-(4-methyl-2-pyridinyl)-1-benzothiophene-2-carboxamide | | 3,6-dichloro-N-(4-methyl-2-pyridinyl)-1-benzothiophene-2-carboxamide |
| 3,7-dichloro-N-[3-(1-imidazolyl)propyl]-6-methoxy-1-benzothiophene-2-carboxamide | | 3,7-dichloro-N-[3-(1-imidazolyl)propyl]-6-methoxy-1-benzothiophene-2-carboxamide |
| abbott 66193 | | Dehydroxyzyleuton |
| ANA-12 | A secondary carboxamide that is anthranilic acid in which the carboxy group has undergone condensation with the primary amino group of alpha-amino-epsilon-caprolactam, while the aryl-amino group has undergone condensation with the carboxy group of 1-benzothiophene-2-carboxylic acid. It is a selective, non-competitive antagonist of tropomyosin receptor kinase B (TrkB, also known as tyrosine receptor kinase B). | ANA-12 |
| benzothiophene | | 1-benzothiophene |
| gsk 1016790a | A tertiary carboxamide that is piperazine in which one of the amino groups has undergone condensation with the carboxy group of N-[(2,4-dichlorophenyl)sulfonyl]-L-serine, while the other has undergone condensation with the carboxy group of N-(1-benzothiophen-2-ylcarbonyl)-L-leucine. It is a cell-permeable, potent and selective agonist of the TRPV4 (transient receptor potential vanilloid 4) channel. | GSK1016790A |
| ly 117018 | A member of the class of 1-benzothiophenes that is raloxifene in which the piperidin-1-yl group has been replaced by a pyrrolidin-1-yl group. | LY 117018 |
| metizoline | | metizoline |
| N-(1-benzothiophen-7-ylmethyl)-2-thiophenecarboxamide | | N-(1-benzothiophen-7-ylmethyl)-2-thiophenecarboxamide |
| N-phenyl-2-benzo[g][1]benzothiolecarboxamide | | N-phenyl-2-benzo[g][1]benzothiolecarboxamide |
| N,N-bis(2-methoxyethyl)-2-thieno[3,2-b][1]benzothiolecarboxamide | | N,N-bis(2-methoxyethyl)-2-thieno[3,2-b][1]benzothiolecarboxamide |
| N2-phenyl-3-methylbenzo[b]thiophene-2-carbothioamide | | N2-phenyl-3-methylbenzo[b]thiophene-2-carbothioamide |
| raloxifene | A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogens at positions 2, 3, and 6 have been replaced by p-hydroxyphenyl, p-[2-(piperidin-1-yl)ethoxy]benzoyl, and hydroxy groups, respectively. | raloxifene |
| sertaconazole | A member of the class of imidazoles that carries a 2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl group at position 1. | 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole |
| stattic | A member of the class of 1-benzothiophenes that is 1-benzothiophene-1,1-dioxide substituted at position 6 by a nitro group. Used as a radiosensitising agent for esophageal squamous cell carcinoma. | stattic |
| zileuton | A member of the class of 1-benzothiophenes that is 1-benzothiophene in which the hydrogen at position 2 is replaced by a 1-[carbamoyl(hydroxy)amino]ethyl group. A selective 5-lipoxygenase inhibitor, it inhibits the formation of leukotrienes LTB4, LTC4, LDT4, and LTE4. It is used for the management of chronic asthma. | zileuton |